[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350553-105":59,"doc-detail-350553-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dh-27-a-right-half-derivative-of-renieramycin-t-induce-apoptosis-through-inhibition-of-mtor-signaling-for-lung-cancer-suppression","DH 27 - a Right-Half Derivative of Renieramycin T - Induce Apoptosis Through Inhibition of mTOR Signaling for Lung Cancer Suppression","","Inhibition of the mTOR signaling pathway is investigated as a targeted strategy for suppressing lung cancer. The study synthesizes DH_27, a right-half derivative of renieramycin T, and evaluates its anticancer activity in NSCLC cells. Cell viability is assessed using MTT and colony formation assays, while apoptosis is analyzed via Hoechst33342/PI and Annexin V-FITC/PI with flow cytometry. Mechanistic studies include JC-1 for mitochondrial depolarization and protein analysis for apoptosis-related markers and mTOR pathway components. Molecular docking and dynamics reveal stable DH_27 interactions at allosteric and catalytic mTOR sites that downregulate p-mTOR/mTOR and downstream Akt and p85S6K signaling, reducing growth and promoting intrinsic apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dh-27-a-right-half-derivative-of-renieramycin-t-induce-apoptosis-through-inhibition-of-mtor-signaling-for-lung-cancer-suppression/350553/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dh-27-a-right-half-derivative-of-renieramycin-t-induce-apoptosis-through-inhibition-of-mtor-signaling-for-lung-cancer-suppression/350553.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is DH_27 and how was it evaluated in lung cancer cells?","Question",{"text":112,"@type":113},"DH_27 is a right-half derivative of renieramycin T. Its cytotoxicity is assessed using MTT and colony formation assays, and apoptosis is measured using Hoechst33342/PI and Annexin V-FITC/PI with flow cytometry.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does DH_27 trigger apoptosis mechanistically?",{"text":117,"@type":113},"DH_27 induces apoptosis, shown by reduced Bcl-2 and increased cleavage of PARP and caspase-9. JC-1 staining indicates mitochondrial depolarization, supporting activation of the intrinsic apoptosis pathway.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does mTOR inhibition play in DH_27’s anticancer effect?",{"text":121,"@type":113},"DH_27 significantly downregulates p-mTOR/mTOR, disrupting downstream signaling including Akt and p85S6K. Molecular docking and molecular dynamics support that DH_27 forms stable interactions at both allosteric and catalytic mTOR sites.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350553,1790175806,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDH  27, a right-half derivative of renieramycinT, induce apoptosis through inhibition of mTOR signaling for lung cancer suppression  \nKorrakod Petsri1􀀍, Masashi Yokoya2, Satapat Racha3,4,5, Zin Zin Ei3,4, Rikako Yamashita2, Daiki Hotta2, Naoki Saito2, Pinkawas Kongmalai6 & Pithi Chanvorachote3,4,7,8􀀍  \nInhibition of mTOR signaling pathway gains a lot of interests as promising strategies for cancer treatment. Recently, we have reported the anticancer potential of the other renieramycinT (RT) right-half compounds. The subsequent modifications were conducted to identify a novel compound capable of exerting anticancer activity through the inhibition of survival proteins and anti-apoptotic proteins. The right-half of RT analog, DH_ 27 was synthesized, and its activity was explored in this study. The cytotoxicity effects were defined with MTT assay and colony formation assay. The induction of apoptosis was elucidated through Hoechst33342/propidium iodide (PI) staining and Annexin V-FITC/ PI staining, coupled with flow cytometry. Mitochondrial membrane potential was assessed using JC-1 staining to investigate mitochondrial-mediated apoptosis. An examination of apoptotic-related proteins and mTOR signaling proteins were evaluated. Binding affinity of DH_27 and mTOR and the stability of DH_27-stabilized protein–protein interactions were investigated using molecular docking and molecular dynamics simulation. DH_27 exhibited cytotoxic effects on NSCLC cells with an IC50 below 10 µM and hindered their ability to form colonies. Treatment with DH_27 induced apoptosis, as evidenced by reduced levels of the anti-apoptotic protein Bcl-2 and increased cleavage of PARP and caspase-9. JC-1 staining revealed mitochondrial depolarization in DH_ 27-treated cells, further supporting apoptosis via the intrinsic pathway. Notably, DH_27 significantly downregulated p-mTOR/ mTOR expression through stable interactions at both the allosteric and catalytic sites, leading to the suppression of downstream signaling pathways, including Akt and p85S6K. This study identifies DH_27 as a potent anticancer agent that inhibits mTOR through allosteric and catalytic mechanisms, suppressing Akt and p85S6K signaling. This leads to reduced cell growth and apoptosis, supporting DH_ 27 as a promising candidate for targeted anticancer therapy.  \nKeywords Derivatives of renieramycin T right-half analog, Lung cancer, Apoptosis, mTOR signaling pathway  \nLung cancer stands as the leading cause of cancer-related fatalities and ranks as the second most frequently documented malignancy globally1. Non-small-cell lung cancer (NSCLC) emerges as the predominant subtypes, with comprising 80–85% of cases2. The overall prognosis is generally poor due to cancer’s recurrence and drug resistance2. Therefore, numerous studies are required to identify new cancer treatment strategies.  \n1Department of Pharmacology, Faculty of Medicine, Kasetsart University, Bangkok, Thailand. 2Department of Pharmaceutical Chemistry, Meiji Pharmaceutical University, Noshio, Kiyose, Tokyo, Japan. 3Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. 4Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. 5Interdisciplinary Program in Pharmacology, Graduate School, Chulalongkorn University, Bangkok, Thailand. 6Department of Orthopedics, Faculty of Medicine, Kasetsart University, Bangkok, Thailand. 7Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand. 8Sustainable Environmental Research Institute, Chulalongkorn University, Bangkok, Thailand. 􀀍 email: [korrakod.p@ku.ac.th](korrakod.p@ku.ac.th); [pithi.c@chula.ac.th](pithi.c@chula.ac.th)  \nInhibition of key proteins in survival pathways gains a lot of interests as promising strategies for lung cancer treatment because th","cbCait3C8JmQwpzk","https://ap.wps.com/l/cbCait3C8JmQwpzk","pdf",9306791,18,"English","# Introduction\n## Lung cancer background and need for new therapies\n## mTOR signaling in apoptosis and cancer progression\n## Renieramycin T and its derivatives\n# Methods and Experimental Approach\n## Synthesis of DH_27\n## Cytotoxicity assays\n## Apoptosis and mitochondrial assays\n## Protein evaluation and signaling analysis\n## Molecular docking and molecular dynamics\n# Results and Findings\n## DH_27 cytotoxicity and colony formation inhibition\n## Apoptosis induction and intrinsic pathway evidence\n## Downregulation of mTOR and downstream signaling via stable binding","[{\"question\":\"What is DH_27 and how was it evaluated in lung cancer cells?\",\"answer\":\"DH_27 is a right-half derivative of renieramycin T. Its cytotoxicity is assessed using MTT and colony formation assays, and apoptosis is measured using Hoechst33342/PI and Annexin V-FITC/PI with flow cytometry.\"},{\"question\":\"How does DH_27 trigger apoptosis mechanistically?\",\"answer\":\"DH_27 induces apoptosis, shown by reduced Bcl-2 and increased cleavage of PARP and caspase-9. JC-1 staining indicates mitochondrial depolarization, supporting activation of the intrinsic apoptosis pathway.\"},{\"question\":\"What role does mTOR inhibition play in DH_27’s anticancer effect?\",\"answer\":\"DH_27 significantly downregulates p-mTOR/mTOR, disrupting downstream signaling including Akt and p85S6K. Molecular docking and molecular dynamics support that DH_27 forms stable interactions at both allosteric and catalytic mTOR sites.\"}]","DH 27 - a Right-Half Derivative of Renieramycin T - Induce Apoptosis Through Inhibition of mTOR Signaling for Lung Cancer Suppression | PDF",1790089561,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea2e0cfb4a4218c450df935d9a252e5a.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c4700ab63d2e3ab80dd43808abad26b.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6165dfac81954d14c5b6a8d8836df3dd.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/198338f2b19f05d192644e98c40daf50.webp",980,1287]